Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Membrane Antigen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06919159
What this trial is testing

Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate-specific Membrane AntigenPositron Emission Tomography (PET)
Jiequn Yu 45
Not applicableStudy completedNCT03187990
What this trial is testing

Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA

Who this might be right for
Prostate Cancer
Irene Burger 52
Testing effectiveness (Phase 2)UnknownNCT05820724
What this trial is testing

PSMA PET Scan and mpMRI for Prostate Cancer Detection

Who this might be right for
Prostate Cancer Diagnosis
VA Greater Los Angeles Healthcare System 100
Early research (Phase 1)Study completedNCT01417182
What this trial is testing

Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Not applicableStudy completedNCT03857087
What this trial is testing

68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer

Who this might be right for
Ovarian Carcinoma
University of California, San Francisco 7
Large-scale testing (Phase 3)Active Not RecruitingNCT04689828
What this trial is testing

177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Novartis Pharmaceuticals 469
Large-scale testing (Phase 3)Not Yet RecruitingNCT07725523
What this trial is testing

Safety and Efficacy of OTL78 (Zopocianine)

Who this might be right for
Prostate Cancer SurgeryProstate Cancer Metastatic Disease
Clinton Bahler 36
Testing effectiveness (Phase 2)Study completedNCT06849544
What this trial is testing

Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection

Who this might be right for
Prostate Cancer SurgeryProstate Cancer Metastatic Disease
Clinton Bahler 22
Early research (Phase 1)Ended earlyNCT04740034
What this trial is testing

AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 42
Testing effectiveness (Phase 2)Study completedNCT01856933
What this trial is testing

BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)

Who this might be right for
GBMGlioblastoma MultiformeGliosarcoma
Heinrich Elinzano, MD 6
Testing effectiveness (Phase 2)Study completedNCT03490032
What this trial is testing

68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)

Who this might be right for
Prostate Cancer Metastatic
Advanced Accelerator Applications 30
Early research (Phase 1)Study completedNCT03427476
What this trial is testing

CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Cancer Targeted Technology 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT07047118
What this trial is testing

JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Cancer, Castration-Resistant
Novartis Pharmaceuticals 138
Testing effectiveness (Phase 2)Ended earlyNCT05489991
What this trial is testing

TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Tceleron Therapeutics, Inc. 1
Testing effectiveness (Phase 2)Looking for participantsNCT07393867
What this trial is testing

Androgen-responsive POSLUMA-guided Intra-prostatic Boost

Who this might be right for
Intermediate Risk Prostate CancerHigh Risk Prostate CancerProstate Cancer
Martin T. King, MD, PhD 23
Not applicableStudy completedNCT05134064
What this trial is testing

68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer

Who this might be right for
PET/CTProstate Specific Membrane AntigenIMAGE
RenJi Hospital 66
Testing effectiveness (Phase 2)Study completedNCT04936334
What this trial is testing

The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer

Who this might be right for
Prostate Cancer
Clinton Bahler 51
Large-scale testing (Phase 3)Study completedNCT04186845
What this trial is testing

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 391
Early research (Phase 1)Looking for participantsNCT06531499
What this trial is testing

Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Novartis Pharmaceuticals 106
Not applicableUnknownNCT03876912
What this trial is testing

The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Turku University Hospital 35
Next Page